Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.36 - $1.59 $2,611 - $11,533
7,254 Added 2.07%
357,690 $141,000
Q3 2022

Nov 14, 2022

BUY
$1.26 - $2.09 $8,273 - $13,722
6,566 Added 1.91%
350,436 $494,000
Q2 2022

Aug 12, 2022

SELL
$0.97 - $3.08 $241,936 - $768,210
-249,419 Reduced 42.04%
343,870 $412,000
Q1 2022

May 13, 2022

BUY
$2.55 - $5.23 $105,445 - $216,265
41,351 Added 7.49%
593,289 $1.72 Million
Q4 2021

Feb 11, 2022

BUY
$4.43 - $8.33 $104,831 - $197,121
23,664 Added 4.48%
551,938 $2.45 Million
Q3 2021

Nov 12, 2021

BUY
$6.07 - $9.89 $152,253 - $248,070
25,083 Added 4.98%
528,274 $3.85 Million
Q2 2021

Aug 13, 2021

BUY
$9.76 - $14.15 $970,075 - $1.41 Million
99,393 Added 24.61%
503,191 $4.92 Million
Q1 2021

May 12, 2021

BUY
$7.66 - $13.38 $887,824 - $1.55 Million
115,904 Added 40.26%
403,798 $4.78 Million
Q4 2020

Feb 12, 2021

SELL
$6.1 - $7.94 $3,275 - $4,263
-537 Reduced 0.19%
287,894 $2.26 Million
Q3 2020

Nov 13, 2020

BUY
$6.52 - $8.94 $55,485 - $76,079
8,510 Added 3.04%
288,431 $1.96 Million
Q2 2020

Aug 13, 2020

BUY
$6.18 - $10.76 $54,915 - $95,613
8,886 Added 3.28%
279,921 $2.1 Million
Q1 2020

May 14, 2020

BUY
$6.03 - $15.24 $74,741 - $188,899
12,395 Added 4.79%
271,035 $1.7 Million
Q4 2019

Feb 13, 2020

BUY
$9.07 - $15.84 $137,328 - $239,833
15,141 Added 6.22%
258,640 $3.92 Million
Q3 2019

Nov 12, 2019

BUY
$9.63 - $14.0 $30,883 - $44,898
3,207 Added 1.33%
243,499 $2.5 Million
Q2 2019

Aug 14, 2019

BUY
$13.4 - $17.67 $1.6 Million - $2.11 Million
119,354 Added 98.69%
240,292 $3.54 Million
Q1 2019

May 14, 2019

BUY
$5.7 - $19.7 $565,434 - $1.95 Million
99,199 Added 456.32%
120,938 $1.99 Million
Q4 2018

Feb 13, 2019

BUY
$5.57 - $11.65 $36,344 - $76,016
6,525 Added 42.89%
21,739 $123,000
Q3 2018

Nov 13, 2018

BUY
$11.32 - $15.7 $172,222 - $238,859
15,214 New
15,214 $182,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.